Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,372.00
-13.00 (-0.55%)
At close: Aug 21, 2026
Mankind Pharma Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Mankind Pharma stock has a consensus rating of "Buy" and an average price target of ₹2,742. The average 1-year stock price forecast is 15.59% higher than the current stock price, while the lowest is ₹2,057 (-13.28%) and the highest is ₹3,220 (+35.75%).
Price Target: ₹2,742 (+15.59%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mankind Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 6 | 5 | 5 |
| Buy | 8 | 8 | 8 | 9 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 3 | 3 |
| Sell | 2 | 2 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 20 | 20 | 19 | 19 |
Financial Forecast
Revenue This Year
160.50B
from 142.78B
Increased by 12.42%
Revenue Next Year
179.23B
from 160.50B
Increased by 11.67%
EPS This Year
57.29
from 51.96
Increased by 10.25%
EPS Next Year
70.51
from 57.29
Increased by 23.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.